| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmaceutics, namely to the application of a probiotic of the species Lactobacillus rhamnosus in preparing a composition for normalising a patient's pathological lipid profile, wherein the above profile comprises lysophospholipid and/or ceramide sphingolipid. A method for normalising the patient's pathological lipid profile by administering the probiotic of the species Lactobacillus rhamnosus in an amount sufficient to achieve the desired effect, into the patient.EFFECT: using the probiotic of the species Lactobacillus rhamnosus as a part of the composition enables normalising the patient's pathological lipid profile comprising lysophospholipid and/or ceramide sphingolipid.12 cl, 2 tbl, 4 dwg, 1 ex |
